Skip to main content

Journal of Cancer Education

Ausgabe 4/2023

Inhalt (39 Artikel)

Editorial

With Gratitude

Maria C. Bishop

Open Access

A Systematic Review of Evidence-Based High School Melanoma Prevention Curricula

Gina N. Calco, Victoria E. Orfaly, Carter K. Haag, Andrew Hamilton, Elizabeth Stoos, Sancy A. Leachman

Assessing the Educational Value of Pancreatic Cancer Videos on YouTube®

Subhash C. Garikipati, Udhayvir Singh Grewal, Shiva Jashwanth Gaddam, Aakash Rajendra Sheth, Hrishikesh Samant

Occupational Sun Exposure Among Physical Education Teachers in Primary and Secondary Schools in Andalusia, Spain

Diego Rodríguez Barón, Nuria Blázquez Sánchez, Francisco Rivas Ruiz, Alba Rodríguez Martínez, José Aguilera Arjona, Guillermo de Castro Maqueda, Inés Gómez Araujo, Maria Victoria de Gálvez Aranda, Antonio Rodríguez Martínez, Magdalena de Troya Martín

Evaluating Healthcare Professionals’ Knowledge, Attitudes, Practices and Education Interest in LGBTQ2 + Cancer Care

Nazlin Jivraj, Gilla K. Shapiro, Christian Schulz-Quach, Emily Van de Laar, Zhihui Amy Liu, Jessica Weiss, Jennifer Croke

Exploring Brachytherapy Discharge Educational Needs of Gynecological Cancer Patients

Anet Julius, Jennifer Croke, Eleni Giannopoulos, Jodi Ann Manhertz, Karen Lawrie, Naa Kwarley Quartey, Janet Papadakos

Open Access

Patient Understanding of Chemotherapy and Goals of Care as Provided by Different Care Team Members

Shanzay Suhail, Sandeep Basu, Sameer A. Batoo, Eyad S. Al-Hattab, Ola Kanj Ahmed, Barbara J. Eidahl, Scott H. Okuno

Thyroid Cancer Risk Communication in Patients with Thyroid Nodules

Diliara Bagautdinova, Shu Wang, Juan P. Brito, Carma L. Bylund, Catherine Edwards, Natalie Silver, Deepa Danan, Debbie Treise, Spyridoula Maraka, Ian Hargraves, Naykky Singh Ospina

Seeking Racial Equity in Hematology and Oncology: a Fellow-Led Educational Series to Promote Reflection and Action

Jacob N. Stein, Jacquelyne J. Gaddy, Jonathan D. Sorah, Melissa Wooten, Keisha Gibson, Frances A. Collichio

Survey of Clinical Providers and Allied Health Staff at a National Cancer Institute-Designated Comprehensive Cancer Center: Cultural Awareness in the Care of LGBTQ2S + Patients with Cancer

Jason D. Domogauer, Mia Charifson, Megan E. Sutter, Megan Haseltine, Rachel Nelson, Marina Stasenko, Abraham Chachoua, Gwendolyn P. Quinn

Open Access

One Website to Gather them All: Usability Testing of the New German SKin Cancer INFOrmation (SKINFO) Website—A Mixed-methods Approach

Theresa Steeb, Julia Brütting, Lydia Reinhardt, Julia Hoffmann, Nina Weiler, Markus V. Heppt, Michael Erdmann, Astrid Doppler, Christiane Weber, Dirk Schadendorf, Friedegund Meier, Carola Berking

Open Access

Institutional barriers to clinical trial exploration experienced by the Latinx community

Sabrina Sandoval, Ringo K. Leung, France Nguyen-Grozavu, Regina M. Wang, Georgia Robins Sadler

Using Community Health Advisors to Increase Lung Cancer Screening Awareness in the Black Belt: a Pilot Study

Soumya J. Niranjan, William Opoku-Agyeman, Claudia M. Hardy, Tara Bowman, Agasthya Vedre-Kyanam, Kristine Ria Hearld, Mark T. Dransfield, Monica L. Baskin

Development and Evaluation of Brief Web-Based Education for Primary Care Providers to Address Inequities in Lung Cancer Screening and Smoking Cessation Treatment

Laney Smith, Randi M. Williams, Julia Whealan, Allison Windels, Eric D. Anderson, Vicky Parikh, Chavalia Joan Breece, Namita Puran, Andrea K. Shepherd, Maria Geronimo, George Luta, Lucile Adams-Campbell, Kathryn L. Taylor

Self-efficacy to Get Cancer-Related Information or Advice

Aisha T. Langford, Katrina R. Ellis, Kerli Orellana, Biyanna M. France, Nancy Buderer

Do Radiation Oncology Residents Have a Preferred Radiation Treatment Planning Review Format?

Conley Kriegler, Mustafa Al Balushi, Yiming Michael Zhu, Jordan Hill, Ananya Beruar, Sunita Ghosh, Alysa Fairchild, Diane Severin

Adaptation of a Multimedia Chemotherapy Educational Intervention for Latinos: Letting Patient Narratives Speak for Themselves

Richard E. Leiter, Maria Teresa Bejarano Varas, Keysha Miralda, Yudy Muneton-Castano, Grace Furtado, Anna Revette, Christine Cronin, Heloisa P. Soares, Athalia Lopez, Laura L. Hayman, Ana Cristina Lindsay, Deborah Schrag, Andrea C. Enzinger

Readability of Online Patient Education Materials for Graft-Versus-Host Disease

Trisha Kaundinya, Salma El-Behaedi, Jennifer N. Choi

Preferences for Breast and Cervical Cancer Screening Among Women and Men in Kenya: Key Considerations for Designing Implementation Strategies to Increase Screening Uptake

Robai Gakunga, Zipporah Ali, Asaph Kinyanjui, Madeleine Jones, Esther Muinga, David Musyoki, Miriam Igobwa, Mackuline Atieno, Sujha Subramanian

Pregnancy Health Among Breast Cancer Survivors: Development and Validation of an Educational Package in Iran

Marzieh Azizi, Elham Ebrahimi, Zahra Behboodi Moghadam, Zohreh Shahhosseini, Maryam Modarres

Assessing Spanish Health Literacy and Cervical Cancer Knowledge, Attitudes, and Behaviors in a Student-Run Free Clinic

Nat C. Jones, Anna Ulyanenkova Fusani, Kaitlyn Maria Cox, Valeria Pereira Martinez, Lucy Guerra, Eduardo Gonzalez

Knowledge of Human Papillomavirus (HPV), Attitudes, and Practices Towards Anti-HPV Vaccination Among Israeli Nurses

Rola Khamisy-Farah, Maher Endrawis, Marwan Odeh, Ruba Tuma, Matteo Riccò, Francesco Chirico, Nicola Luigi Bragazzi

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.